Candriam Equities L Biotechnology C - Thesaurierung/ LU0108459040 /
NAV2024-05-13 | Chg.+5.8800 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
826.0500USD | +0.72% | reinvestment | Equity Worldwide | Candriam ▶ |
GlobeNewswire
05-14
Firsthand Technology Value Fund Announces First Quarter Financial Results, NAV of $0.02 Per Share
GlobeNewswire
05-14
Gratus Capital Partners with iCapital® to Launch Hedge Fund Investing Opportunities to Wealth Manage...